E-Z-EM, Inc. to Hold Fiscal 2007 First Quarter Financial Results Conference Call on Tuesday, October 10, 2006.LAKE SUCCESS, N.Y. -- E-Z-EM, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :EZEM) today announced that the company will release fiscal 2007 first quarter financial results after market close on Tuesday, October 10, 2006. Anthony A. Lombardo, president and chief executive officer, and Dennis J. Curtin, chief financial officer, will host an investment conference call beginning at 4:30 p.m. Eastern Time on Tuesday, October 10, 2006 to discuss these results and to answer questions. To participate, please dial 877-815-7177 from the U.S. or 706-679-0753 from outside the U.S. In addition, a telephone replay of the call will be accessible for a limited time following completion of the call by dialing 800-642-1687 or 706-645-9291 and entering reservation number 8040501. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of E-Z-EM's web site at www.ezem.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download, and install the necessary audio software. A replay will be available on the Web site for a limited time. About E-Z-EM, Inc. E-Z-EM is a leading manufacturer of contrast agents for gastrointestinal radiology. The Company recently introduced VoLumen([R]) the next generation low density barium sulfate suspension Barium sulfate suspension is barium sulfate (powder) turned into a liquid form by suspending it in a quick-flowing drink to aid in CT scans of the gastrointestinal region. Use for use as an oral contrast in Multidetector CT (MDCT MDCT Modified Discrete Cosine Transform MDCT Multi-detector Computed Tomography MDCT Multiple Description Correlating Transform MDCT Motorsport Dual Clutch Transmission ) and Positron Emission Tomography positron emission tomography: see PET scan. positron emission tomography (PET) Imaging technique used in diagnosis and biomedical research. (PET/CT PET/CT Positron Emission Tomography and Computed Tomography ) studies. The Company also offers Empower([R]) Co the only family of CT injectors on the market with patented EDA[TM] technology that can help detect contrast extravasation extravasation /ex·trav·a·sa·tion/ (ek-strav?ah-za´shun) 1. a discharge or escape, as of blood, from a vessel into the tissues; blood or other substance so discharged. 2. the process of being extravasated. Co and offers a complete product set for the virtual colonoscopy practitioner. This product line consists of virtual colonoscopy hardware, software, nutritional prep kits and bowel cleaners, tagging agents and a carbon dioxide colon insufflation insufflation /in·suf·fla·tion/ (-sah-fla´shun) 1. the act of blowing a powder, vapor, or gas into a body cavity. 2. finely powdered or liquid drugs carried into the respiratory passages by such devices as aerosols. system. The Company is also the exclusive world-wide manufacturer and marketer of RSDL for first-responder organizations and military services. RSDL is a patented, broad spectrum liquid chemical warfare (CW) agent decontaminant. RSDL neutralizes or removes chemical agents from skin on contact, leaving a non-toxic residue that can be rinsed off with water. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion